Insilico Medicine Hong Kong Limited

This study is testing a new oral medication called INS018_055 for people with idiopathic pulmonary fibrosis (IPF), a serious and progressive lung disease. The main goal is to check if the drug is safe and well-tolerated over 12 weeks of treatment. Researchers will also measure ho…

This is the first study in humans testing a new drug called ISM3412 for people with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will give increasing doses to about 80 participants to find the safest amount and see how the body processes the…

This is the first time a new drug called ISM6331 is being tested in people. The main goal is to find a safe dose and understand its side effects in 100 adults with advanced cancers like mesothelioma or other solid tumors that have not responded to standard treatments. Researchers…

This study is testing an experimental oral medication called ISM5411 for adults with active ulcerative colitis. The drug is designed to work mainly in the gut to help protect the intestinal lining and reduce inflammation. Researchers will compare the drug to a placebo in 80 parti…